Search bioRxiv⌕ Search

Biology subjects

Imrie, F.

Publications and source records attributed to Imrie, F..

7 recordsLinked to original sources

The first OpenBind release: An open experimental structure-affinity dataset and benchmark for structure-based AI

High-quality experimental datasets that link protein-ligand structures with binding affinity data are essential for developing and evaluating structure-based machine learning methods. To help address this need, we established OpenBind as an open-science initiative to generate large-scale experimental datasets for structure-based AI and molecular discovery. Here, we describe the first public OpenBind release, which, to the best of our knowledge, is the largest public single-target experimental structure-affinity dataset. The dataset focuses on enteroviral 2A protease, comprising 925 crystallographic binding events from 699 compounds and associated affinity measurements for 601 compounds. It combines structures from an initial fragment screen and follow-on molecules, together with affinity data, linking experimentally determined protein-ligand binding modes to biophysical measurements within a coherent antiviral discovery campaign. We used this dataset to evaluate protein-ligand structure prediction, binding-affinity prediction, and virtual screening using representative structure-based methods, including docking and cofolding. This exposed several challenges that are central to practical structure-based modelling: docking performance depends strongly on binding-pocket conformation, poses are difficult to rank, and structure-based affinity prediction remains challenging. Fine-tuning OpenFold3-p2 on the fragment-screen structures substantially improved pose prediction and virtual screening for related follow-on compounds, demonstrating how early-stage experimental structures can support target-specific model adaptation.

bioinformatics↗

Teaching Diffusion Models Physics: Reinforcement Learning for Physically Valid Diffusion-Based Docking

Molecular docking aims to predict the binding conformation of a small molecule to its protein target. Recent work has proposed diffusion models for this task, from rigid-body docking that diffuses over ligand degrees of freedom to co-folding approaches that jointly generate protein structure and ligand pose. However, diffusion-based docking models have been shown to frequently produce physically implausible poses and fail to consistently recover key protein-ligand interactions. To address this, we introduce a reinforcement learning framework for training diffusion-based docking models directly on non-differentiable objectives. Fine-tuning DiffDock-Pocket for physical validity with our approach substantially increases the number of generated poses that are physically valid and interaction-preserving, with no increase in inference-time compute. Importantly, this comes without sacrificing structural accuracy; in fact, our approach increases the proportion of structures with near-native poses. These effects are most pronounced for protein targets that are dissimilar to the training data. Our fine-tuned DiffDock-Pocket model outperforms both classical docking algorithms and machine learning-based approaches on the PoseBusters set. Our results demonstrate that reinforcement learning can teach diffusion-based docking models to better respect physical constraints and recover key interactions, without the requirement to rely on inference-time corrections.

bioinformatics↗

Testing the Limits of SMILES-based De Novo Molecular Generation with Curriculum and Deep Reinforcement Learning

1Deep reinforcement learning methods have been shown to be potentially powerful tools for de novo design. Recurrent neural network (RNN)-based techniques are the most widely used methods in this space. In this work, we examine the behaviour of RNN-based methods when there are few (or no) examples of molecules with the desired properties in the training data. We find that targeted molecular generation is often possible, but the diversity of generated molecules is often reduced, and it is not possible to control the composition of generated molecular sets. To help overcome these issues, we propose a new curriculum learning-inspired, recurrent Iterative Optimisation Procedure that enables the optimisation of generated molecules for seen and unseen molecular profiles and allows the user to control whether a molecular profile is explored or exploited. Using our method, we generate specific and diverse sets of molecules with up to 18 times more scaffolds than standard methods for the same sample size. However, our results also point to significant limitations of one-dimensional molecular representations as used in this space. We find that the success or failure of a given molecular optimisation problem depends on the choice of SMILES.

bioinformatics↗

Incorporating Target-Specific Pharmacophoric Information Into Deep Generative Models For Fragment Elaboration

Despite recent interest in deep generative models for scaffold elaboration, their applicability to fragment-to-lead campaigns has so far been limited. This is primarily due to their inability to account for local protein structure or a users design hypothesis. We propose a novel method for fragment elaboration, STRIFE that overcomes these issues. STRIFE takes as input Fragment Hotspot Maps (FHMs) extracted from a protein target, and processes them to provide meaningful and interpretable structural information to its generative model, which in turn is able to rapidly generate elaborations with complementary pharmacophores to the protein. In a large-scale evaluation, STRIFE outperforms existing, structure-unaware, fragment elaboration methods in proposing highly ligand efficient elaborations. In addition to automatically extracting pharmacophoric information from a protein targets FHM, STRIFE optionally allows the user to specify their own design hypotheses.

systems biology↗

Deep Generative Design with 3D Pharmacophoric Constraints

Generative models have increasingly been proposed as a solution to the molecular design problem. However, it has proved challenging to control the design process or incorporate prior knowledge, limiting their practical use in drug discovery. In particular, generative methods have made limited use of three-dimensional (3D) structural information even though this is critical to binding. This work describes a method to incorporate such information and demonstrates the benefit of doing so. We combine an existing graph-based deep generative model, DeLinker, with a convolutional neural network to utilise physically-meaningful 3D representations of molecules and target pharmacophores. We apply our model, DEVELOP, to both linker and R-group design, demonstrating its suitability for both hit-to-lead and lead optimisation. The 3D pharmacophoric information results in improved generation and allows greater control of the design process. In multiple large-scale evaluations, we show that including 3D pharmacophoric constraints results in substantial improvements in the quality of generated molecules. On a challenging test set derived from PDBbind, our model improves the proportion of generated molecules with high 3D similarity to the original molecule by over 300%. In addition, DEVELOP recovers 10 x more of the original molecules compared to the base-line DeLinker method. Our approach is general-purpose, readily modifiable to alternate 3D representations, and can be incorporated into other generative frameworks. Code is available at https://github.com/oxpig/DEVELOP.

bioinformatics↗

Generating Property-Matched Decoy Molecules Using Deep Learning

An essential step in the development of virtual screening methods is the use of established sets of actives and decoys for benchmarking and training. However, the decoy molecules in commonly used sets are biased meaning that methods often exploit these biases to separate actives and decoys, rather than learning how to perform molecular recognition. This fundamental issue prevents generalisation and hinders virtual screening method development. We have developed a deep learning method (DeepCoy) that generates decoys to a users preferred specification in order to remove such biases or construct sets with a defined bias. We validated DeepCoy using two established benchmarks, DUD-E and DEKOIS 2.0. For all DUD-E targets and 80 of the 81 DEKOIS 2.0 targets, our generated decoy molecules more closely matched the active molecules physicochemical properties while introducing no discernible additional risk of false negatives. The DeepCoy decoys improved the Deviation from Optimal Embedding (DOE) score by an average of 81% and 66%, respectively, decreasing from 0.163 to 0.032 for DUD-E and from 0.109 to 0.038 for DEKOIS 2.0. Further, the generated decoys are harder to distinguish than the original decoy molecules via docking with Autodock Vina, with virtual screening performance falling from an AUC ROC of 0.71 to 0.63. The code is available at https://github.com/oxpig/DeepCoy. Generated molecules can be downloaded from http://opig.stats.ox.ac.uk/resources.

bioinformatics↗

Deep Generative Models for 3D Compound Design

Rational compound design remains a challenging problem for both computational methods and medicinal chemists. Computational generative methods have begun to show promising results for the design problem. However, they have not yet used the power of 3D structural information. We have developed a novel graph-based deep generative model that combines state-of-the-art machine learning techniques with structural knowledge. Our method (\"DeLinker\") takes two fragments or partial structures and designs a molecule incorporating both. The generation process is protein context dependent, utilising the relative distance and orientation between the partial structures. This 3D information is vital to successful compound design, and we demonstrate its impact on the generation process and the limitations of omitting such information. In a large scale evaluation, DeLinker designed 60% more molecules with high 3D similarity to the original molecule than a database baseline. When considering the more relevant problem of longer linkers with at least five atoms, the outperformance increased to 200%. We demonstrate the effectiveness and applicability of this approach on a diverse range of design problems: fragment linking, scaffold hopping, and proteolysis targeting chimera (PROTAC) design. As far as we are aware, this is the first molecular generative model to incorporate 3D structural information directly in the design process. Code is available at https://github.com/oxpig/DeLinker.

bioinformatics↗